Key Points
- Characterize the clinical syndromes and epidemiologic patterns associated with the six serotypes of Coxsackie group B viruses.
- Synthesized clinical observations and epidemiological investigations of outbreaks attributed to Coxsackie group B viral infections.
- Evaluated diagnostic recovery, serotype classification based on suckling mouse pathology, and associated disease presentations across patient demographics.
- Group B Coxsackieviruses comprise six antigenically distinct serotypes capable of causing widespread seasonal community epidemics.
- Major clinical presentations include pleurodynia (severe chest and abdominal muscle pain) and acute aseptic meningitis across pediatric and adult populations.
- Infantile infections carry a high risk of generalized systemic disease, presenting predominantly as severe and potentially fatal encephalomyocarditis.
Structured PICO
PPopulationPatients with Coxsackie Group B virus infections
Coxsackie Group B viruses are recognized as a cause of encephalomyocarditis in infants, alongside other clinical manifestations like aseptic meningitis and pleurodynia.